Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

68.55

-0.02 (-0.03%)

At close: Jun 18, 2026, 4:00 PM EDT

68.61

+0.06 (0.09%)

After-hours: Jun 18, 2026, 6:20 PM EDT

Halozyme Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	8,131	7,927	5,887	4,685	7,690	5,529
Market Cap Growth	22.54%	34.64%	25.65%	-39.07%	39.09%	-4.70%
Enterprise Value	9,989	9,927	6,797	5,849	8,834	5,665
Last Close Price	68.55	67.30	47.81	36.96	56.90	40.21
PE Ratio	24.13	26.29	13.94	17.60	39.51	14.68
Forward PE	7.78	8.85	10.38	9.77	21.92	17.89
PS Ratio	5.39	5.68	5.80	5.65	11.65	12.47
PB Ratio	36.99	162.39	16.18	55.91	45.29	28.07
P/TBV Ratio	-	-	-	-	-	29.97
P/FCF Ratio	12.18	12.30	12.57	12.55	32.68	18.55
P/OCF Ratio	12.00	12.17	12.29	12.06	32.03	18.46
EV/Sales Ratio	6.62	7.11	6.69	7.05	13.38	12.78
EV/EBITDA Ratio	10.48	17.82	10.74	13.85	27.85	20.31
EV/EBIT Ratio	11.63	21.17	12.33	17.33	33.02	20.53
EV/FCF Ratio	14.96	15.40	14.51	15.67	37.54	19.01
Debt / Equity Ratio	8.81	43.89	4.14	17.89	8.79	4.00
Debt / EBITDA Ratio	3.50	3.85	2.38	3.55	4.75	3.14
Debt / FCF Ratio	3.21	3.32	3.22	4.02	6.40	2.94
Net Debt / Equity Ratio	8.31	40.97	2.50	13.88	6.73	0.69
Net Debt / EBITDA Ratio	2.98	3.59	1.44	2.75	3.61	0.49
Net Debt / FCF Ratio	2.74	3.10	1.94	3.12	4.86	0.46
Asset Turnover	0.58	0.61	0.53	0.46	0.45	0.53
Inventory Turnover	1.56	1.44	1.18	1.69	1.81	1.42
Quick Ratio	2.14	3.30	6.50	5.07	4.54	7.10
Current Ratio	2.76	4.66	7.80	6.64	5.65	7.91
Return on Equity (ROE)	259.89%	153.59%	198.42%	222.07%	110.23%	231.44%
Return on Assets (ROA)	13.65%	13.87%	23.16%	15.27%	14.75%	53.09%
Return on Invested Capital (ROIC)	16.11%	18.02%	33.64%	20.63%	25.58%	117.40%
Return on Capital Employed (ROCE)	21.98%	21.95%	31.11%	20.27%	19.83%	48.16%
Earnings Yield	4.29%	3.80%	7.17%	5.68%	2.53%	6.81%
FCF Yield	8.21%	8.13%	7.96%	7.97%	3.06%	5.39%
Buyback Yield / Dilution	4.58%	4.27%	3.56%	4.56%	4.22%	-3.77%
Total Shareholder Return	4.58%	4.27%	3.56%	4.56%	4.22%	-3.77%

SEC Filings: 10-K · 10-Q